Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity.

Yeon Choi K, Qin Y, El-Hamdi N, McGregor A

Open source

DOI
10.64898/2026.10.28.762556
Published
2026 Oct 29
Container
bioRxiv : the preprint server for biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.28.762556,
  title = {Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity.},
  author = {Yeon Choi K and Qin Y and El-Hamdi N and McGregor A},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.10.28.762556},
  url = {https://doi.org/10.64898/2026.10.28.762556}
}

RIS

TY  - JOUR
TI  - Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity.
AU  - Yeon Choi K
AU  - Qin Y
AU  - El-Hamdi N
AU  - McGregor A
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.10.28.762556
UR  - https://doi.org/10.64898/2026.10.28.762556
ER  - 

APA

K, Y. C., Y, Q., N, E., & A, M. (2026). Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.28.762556

Source records